BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33974471)

  • 1. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
    Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
    Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid oligosaccharide-modified zeolitic imidazolate framework-8 nanoparticles loaded with oxaliplatin as a targeted drug-delivery system for colorectal cancer therapy.
    Li B; Zhang Z; He S; Du W; Yang X; Kou B; Jiang Y; Bian P; Yin L
    Nanomedicine (Lond); 2023 May; 18(12):891-905. PubMed ID: 37409459
    [No Abstract]   [Full Text] [Related]  

  • 3. Folate conjugated hyaluronic acid coated alginate nanogels encapsulated oxaliplatin enhance antitumor and apoptosis efficacy on colorectal cancer cells (HT29 cell line).
    Shad PM; Karizi SZ; Javan RS; Mirzaie A; Noorbazargan H; Akbarzadeh I; Rezaie H
    Toxicol In Vitro; 2020 Jun; 65():104756. PubMed ID: 31884114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
    Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
    Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy.
    Yang C; Liu Y; He Y; Du Y; Wang W; Shi X; Gao F
    Biomaterials; 2013 Sep; 34(28):6829-38. PubMed ID: 23764114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
    Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
    Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.
    Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J
    Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor RNA-loaded nanoliposomes increases the anti-tumor immune response in colorectal cancer.
    Dai D; Yin Y; Hu Y; Lu Y; Zou H; Lu G; Wang Q; Lian J; Gao J; Shen X
    Drug Deliv; 2021 Dec; 28(1):1548-1561. PubMed ID: 34286631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier.
    Ye H; Chu X; Cao Z; Hu X; Wang Z; Li M; Wan L; Li Y; Cao Y; Diao Z; Peng F; Liu J; Xu L
    Int J Nanomedicine; 2021; 16():1051-1066. PubMed ID: 33603368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting LAYN inhibits colorectal cancer metastasis and tumor-associated macrophage infiltration induced by hyaluronan oligosaccharides.
    Yang Y; Chen Z; Chu X; Yan Q; He J; Guo Y; Zhao Z; Zhang Y; Hu D; Ding H; Zhao X; Pan Y; Dong H; Wang L; Pan J
    Matrix Biol; 2023 Mar; 117():15-30. PubMed ID: 36805871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer.
    Sun Y; Xie Y; Tang H; Ren Z; Luan X; Zhang Y; Zhu M; Lv Z; Bao H; Li Y; Liu R; Shen Y; Zheng Y; Pei J
    Int J Nanomedicine; 2021; 16():8279-8303. PubMed ID: 34992365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma.
    Yang H; Liu Y; Qiu Y; Ding M; Zhang Y
    Int J Pharm; 2019 Jul; 566():585-593. PubMed ID: 31181310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
    Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
    Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
    Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
    J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
    Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
    Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
    Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription.
    Zuo Q; Xu Q; Li Z; Luo D; Peng H; Duan Z
    Anticancer Drugs; 2023 Nov; 34(10):1171-1182. PubMed ID: 37067981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.
    Wang Z; Zang A; Wei Y; An L; Hong D; Shi Y; Zhang J; Su S; Fang G
    Drug Des Devel Ther; 2020; 14():1095-1105. PubMed ID: 32210538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.